“Delaying the Onset of Type 1 Diabetes With Teplizumab: A Narrative Review of Autoantibody Screening and Who Would Actually Be Treated”. Journal of Clinical Diabetes and Obesity, vol. 2, no. 1, Oct. 2022, pp. 7-12, https://doi.org/10.5281/zenodo.22238844.